148

Indi Adressing Final

Embed Size (px)

DESCRIPTION

Wound Care Dressing overview presented to a physician and nursing class at CMC in Vellore,India

Citation preview

Page 1: Indi Adressing Final
Page 2: Indi Adressing Final
Page 3: Indi Adressing Final

Ambrose Pare 1520 to 1590

“ I dress the wounds God Heals them”

Page 4: Indi Adressing Final
Page 5: Indi Adressing Final

Wound Dressing Basics

• Thorough wound cleansing is the first step with each dressing change.

Page 6: Indi Adressing Final

Wound Dressing Basics

• Fill wound cavities/dead space

Page 7: Indi Adressing Final

Wound Dressing Basics

• Protect periwound skin

Page 8: Indi Adressing Final

Wound Dressing Basics

• Avoid adhesives on friable skin

Page 9: Indi Adressing Final

Wound Care Basics

• Always use a skin prep and allow to dry before applying adhesive

Page 10: Indi Adressing Final

Three Key Components of Local Wound Care

• Moist interactive healing

• Debridement

• Bacterial balance/prolonged inflammation

Page 11: Indi Adressing Final
Page 12: Indi Adressing Final
Page 13: Indi Adressing Final
Page 14: Indi Adressing Final

Comparison of maintaining moist versus open wound

• Moisture increases re-epithelialization by 30 – 50%

• Moisture increases collagen synthesis by 50%

• Rate of epithelialization with moisture 2 to 5 times faster

• Marked decrease in wound surface fluid loss

Page 15: Indi Adressing Final

Advantages of moist wound surface

• Decrease in surface dessication and eschar formation

• Increase in local growth factor production • Activation of surface proteases to remove

devitalized tissue• Enhanced wound surface immune defenses• Increased rate of angiogenesis and fibroblast

proliferation• Increased proliferation and migration of epithelial

cells along thin water layer

Page 16: Indi Adressing Final

Moisture is required for:

• Activity of growth factors

• Activity of surface proteolytic enzymes

• Surface oxygen delivery

• More effective nutrient delivery

Page 17: Indi Adressing Final

Potential complications of moist healing

• Infection? Does not appear to be increased in a clean wound, even with nonviable tissue on the surface

• Skin maceration? Does not appear to occur unless exudate is allowed to occur

• Hypergranulation? Seems to be less with moist healing as surface inflammation is less

• Pain? Pain is less

Page 18: Indi Adressing Final
Page 19: Indi Adressing Final

Moist Wound Healing

The moist environment provided by covering a wound (left) allows the epidermal cells to move easily across

the wound surface, healing the wound. In a dry environment (right), the epidermal cells must tunnel down to a moist level and secrete enzymes to lift the

scab away from thw wound surfae before the cells can migrate and begin to allow healing to occur.

Page 20: Indi Adressing Final
Page 21: Indi Adressing Final

Gauze Dressing

• Worldwide still the most common dressing material used• In the chronic wound setting usually employed as “wet to

dry” or “wet to moist”.• Wound is packed with a moistend gauze, covered with a

secondary dry dressing.• Typically changed once or twice daily• Classically described as a way to mechanically debride a

wound.

Page 22: Indi Adressing Final

Gauze dressings: wet to dry

• Heat loss from wound

• Poor bacterial barrier; to and from the wound

• Labour intensive and costly

• don’t work!

Page 23: Indi Adressing Final

Gauze dressings: heat loss

• Open wound 21 C, gauze covered 25 C, semi occlusive 33 C to 35 C

• Cooling causes local vasoconstriction

• Cooling causes impairment of lekocyte mobility and phagocytic efficiency

• Oxygen dissociation curve shifts left, RBC has increased affinity for oxygen

Page 24: Indi Adressing Final

Gauze dressings: poor bacterial barrier

• Provide no physical barrier to entry of exogenous bacteria

• In vitro bacteria able to penetrate 64 layer thick gauze barrier, moistened even worse

• Literature review of 3047 wounds, overall infection rate semi occlusive dressings 2.6%, gauze 7.1%

• Dry and moistend gauze disperse bacteria from the wound into surrounding air with dressing changes. Bacteria remain aerosolized for upto 30 minutes

Page 25: Indi Adressing Final
Page 26: Indi Adressing Final

The real cost of wound care

• The price of the dressing

• The labor cost of having a healthcare professional change the dressing

• Indirect cost of ancillary supplies (eg, gloves, biohazard disposal)

• The cost of duration of care

Page 27: Indi Adressing Final

Gauze: why still popular?

• One size fits all, readily available, familiarity, tradition, percieved as inexpensive

• Advanced dressings don’t easily fit, must stockpile multiple products, multiple sizes

• Multiple choices daunting

Page 28: Indi Adressing Final

Gauze dressings: don’t work

• Wound dessication

• Painful

• Nonselective debridement removes healthy and diseased tissue with change

Page 29: Indi Adressing Final
Page 30: Indi Adressing Final
Page 31: Indi Adressing Final

The Indian Wound Care Market: A review 2004Frost and Sullivan Market Insight

• High rural to urban ratio

• Innumerable geo – socio – cultural variables

• Core development issues like poverty, illiteracy, and nutrition

Page 32: Indi Adressing Final

The Indian Wound Care Market: A review 2004Frost and Sullivan Market Insight

• Combined investment in health by centre and state governments is just 1.3% of GDP

• Reimbursement is negligible, though privatization of the insurance sector has helped

• Of 16,000 hospitals 60% are in the public sector• The populace has low purchasing power, combined with

low health protection

Page 33: Indi Adressing Final

Wound Dressings

Technology and product proliferation varies by

geography, usually as a function of economics and

health care policy.

Page 34: Indi Adressing Final

History Of Dressings

Page 35: Indi Adressing Final

The perfect dressing

• Keeps wound moist• Promotes wound healing• Mechanical protection• Nonadherant to wound bed• Change w/o pain• Absorbs excess exudate• Allows gas exchange• Barrier to bacterial access• Ease of use• Cost (overall)

Page 36: Indi Adressing Final
Page 37: Indi Adressing Final

Biology of Chronic WoundsWound Exudate Burden

Page 38: Indi Adressing Final

Chronic wound fluid

• Elevated proinflammatory cytokines

• High protease activity

• Decreased levels of natural inhibitors to MMPs

• Diminished growth factor activity

Page 39: Indi Adressing Final

Biology of Chronic Wounds Exudate Burden

• Blocks the proliferation and activity of certain cell types, fibroblasts and keratinocytes

• MMPs and proteases in high concentrations

• Proprietary growth factors and bioengineered skin do not fare well well in wound microenvironment that contains high amounts of exudate

Page 40: Indi Adressing Final

Managing moisture balance

Page 41: Indi Adressing Final
Page 42: Indi Adressing Final

Transparent films

Page 43: Indi Adressing Final

Transparent films

• Absorbency = 0• Wear time = 7 days• Polymer sheets coated with adhesive• Impermeable to liquid, water, bacteria• Permeable to moisture vapor and

atmospheric gases• Clear design allows visualization• Re-epithelialization/protectant/cover

dressing

Page 44: Indi Adressing Final

Transparent Films

• Designed around initial moist wound care concepts (Winters)

• Some pain relief

• Aggressive adhesive can be a problem, trauma

• Drainage can collect and disrupt barrier

Page 45: Indi Adressing Final

Hydrogels

Page 46: Indi Adressing Final

Hydrogels

• Absorbency = 1+• Wear time = 12 to 72 hours• Formulations of water , polymers,

propylene glycol• Designed to donate moisture to dry wound• Comes in amorphous,gauze impregnated

sheets• Good for debridement,

granulation,epithelialization

Page 47: Indi Adressing Final

Hydrogels

• Provide high water content in a gel lattice that renders them nonadherent and soothing

• Provide the wound with moisture

Page 48: Indi Adressing Final

Hydrogel

Page 49: Indi Adressing Final
Page 51: Indi Adressing Final

Hydrocolloids

Page 52: Indi Adressing Final

Hydrocolloids

• “water loving”• Elastic, adhesive and gelling agents ( ie. Pectin or

gelatin)• Change once every 3 to 7 days • Frequency of change depends on drainage, shear, and

incontinence…)

Page 53: Indi Adressing Final

Hydrocolloids

• Absorbency = 2+

• Wear time 3 to 7 days

• Composed of gelatin , pectin, carboxymethylcellulose

• Vary in thickness, margins

• Good for granulation, debridement, epithelialization; autolytic debridement

Page 54: Indi Adressing Final

Hydrocolloid

Page 55: Indi Adressing Final
Page 56: Indi Adressing Final

Debridement

• Surgical, sharp

• Enzymatic

• Autolytic

Page 57: Indi Adressing Final

Removal of callus andRemoval of callus andnecrotic tissuenecrotic tissueRemoval of callus andRemoval of callus andnecrotic tissuenecrotic tissue

Decreasing the Decreasing the bacterial burdenbacterial burdenDecreasing the Decreasing the bacterial burdenbacterial burden

Removal of Removal of phenotypically altered phenotypically altered cells: the cellular burdencells: the cellular burden

Removal of Removal of phenotypically altered phenotypically altered cells: the cellular burdencells: the cellular burden

Importance of Debridement

Page 58: Indi Adressing Final

Autolytic debridement• The use of synthetic dressings to cover a wound and allow eschar

to self-digest by the action of enzymes present in wound fluid

• Utilizes the bodies own enzymatic machine to dissolve necrotic tissue within the wound, selective

• Moist environment accelerates the process

• Little or no pain

• Sloooow

• Hydrocolloids, hydrogels, transparent films, and alginates

Page 59: Indi Adressing Final

Autolytic Debridement: advantages

• Very selective, with no damage to surrounding skin

• Safe

• Effective, versatile and easy to perform

• Little or no pain

Page 60: Indi Adressing Final

Autolytic Debridement: disadvantages

• Not as rapid as surgical debridement

• Wound must be monitored closely for signs of infection

Page 61: Indi Adressing Final

Calcium Alginates

• Absorbency = 4+• Wear time 1 to 7 days • Natural polysaccharide derived from seaweed• Converts to gel with fluid contact• Rope, sheets, conformable packing• Wicks vertically• Gel block to edges• Good for highly exudating wounds,

granulation;hemostasis and odor control functions

Page 62: Indi Adressing Final

Calcium alginate

Page 63: Indi Adressing Final
Page 64: Indi Adressing Final

Calcium Alginate

Page 65: Indi Adressing Final

Foams

• Absorbency = 4+

• Wear time 1 to 7 days

• Foamed solutions of polymers, polyurethane

• Vary in thickness with or without adhesives

• Good for highly exudating wounds in granulation stage

Page 66: Indi Adressing Final

Foam dressings

Page 67: Indi Adressing Final
Page 68: Indi Adressing Final

Collagens

• Absorbency = 1 – 4+

• Wear time 1 – 5 days

• Exogenous collagen derived from porcine, bovine sources

• Available in sheets, particles, powders, pastes

• Requires secondary dressing

Page 69: Indi Adressing Final

Promogran

• Sterile freeze dried matrix, 45% cellulose,55% collagen

• Packaged as a sheet

• In prescense of wound exudate the matrix absorbs liquid and forms a soft, comortable biodegradable gel

• Binds and inactivates matrix mettalloproteases (MMPs)

Page 70: Indi Adressing Final
Page 71: Indi Adressing Final
Page 72: Indi Adressing Final
Page 73: Indi Adressing Final

Biology of Chronic WoundsBioburden

Page 74: Indi Adressing Final
Page 75: Indi Adressing Final

Bioburden continum

• Colonization

• Critical colonization

• Wound infection

Page 76: Indi Adressing Final

Colonization

• All chronic wounds that heal will do so in a colonized state

• Infection in chronic wounds reflects host susceptibilty

• Significantly greater chance of impaired wound healing when four or more species present

Page 77: Indi Adressing Final

Critical colonization

• 10 to the 5th colonization has no confirmed connection to the threshold or degree of immune response or to healing

• Infection diagnosis often a retrospective diagnosis

• Evidance supports the fact that delayed healing in a chronic wound that has no signs of clinical infection, suggestive of critical colonization, is directly related to microbial bioburden, notably nonhemolytic strep and anaerobes.

• Where wounds are static or exudate levels high, critical colonization or infection should be suspected

Page 78: Indi Adressing Final

Biofilm formation

Page 79: Indi Adressing Final

Critical colonization/infection

• Microbes consume valuable nutrients and oxygen

• White cell function is impaired by short chain fatty acids, endotoxins and subsequent interleukins(TNF), matrix metalloproteases

• Oxygen free radical production• Fibroblast production decreased and

delayed, decreased scar strength

Page 80: Indi Adressing Final
Page 81: Indi Adressing Final
Page 82: Indi Adressing Final

Wound cleansing

• Purpose: remove excess exudate, foreign bodies (retained dressings), necrotic tissue, wound edge crusting/debris

• Should include periwound skin

• Includes: debridement, pressure irrigation, moistend wipe

Page 83: Indi Adressing Final

Wound cleansing

• Sterile normal saline

• Tap water – “the fluid of first choice”

• Hall Angerans et. al, 1992 “tap water presents no quantifiable infection risk”

• Chrintz et. al,1989 in a study of 1,200 head and neck wounds demonstrated no increase in wound infection rate when patients showered postoperatively

Page 84: Indi Adressing Final
Page 85: Indi Adressing Final

Topical antibiotics

• “use of topical antibiotics is not justified for the routine treatment of colonized or infected wounds”

• Can provoke delayed hypersensitivity response

• Select for resistant bacterial strains

• “routine use of topical antibiotics in the management of clinically infected leg ulcers has been shown to be of no benefit and some evidance shows it may be harmful because it encourages colonization by resistant organisms”

Page 86: Indi Adressing Final

Topical antibiotics – metronidazole

• Indicated for malodorous fungating wounds

Page 87: Indi Adressing Final

Topical antibiotics - mupirocin

• Narrow spectrum topical antibiotic developed to eradicate MRSA (nasal)

• Mupirocin low level resistance now common, high level resistance documented

Page 88: Indi Adressing Final

Topical antibiotics - TAO

• Neomycin, polymyxin, bacitracin

• Inhibit coag neg Staph, Pseudomonas aeruginosa

• S. aureus resistance 5%

• TAO use must be balanced by the well known risks of sensitization, particularly when using neomycin, bacitrain

Page 89: Indi Adressing Final
Page 90: Indi Adressing Final

Antiseptics

• A disinfectant substance used on skin and wounds that either kill (cidal) or prevents multiplication (static) of potentially pathologic organisms

• Multiple targets, broad spectrum of activity (bacteria, fungi,viruses,prions)

• Most common: povidine iodine, chlohexidine, acetic acid, hydrogen peroxide, silver, sodium hypochlorite

Page 91: Indi Adressing Final

Antiseptics

• Significant potential for cell toxicity (fibroblasts, keratinocytes,leukocytes)

• Toxicity = formulation, concentration, exposure

• Continue to play a role in surgical skin preps and the heavily contaminated wound

Page 92: Indi Adressing Final

Antiseptics

• Broader spectrum that antibiotics

• Bacterial resistance may be less of an issue

• Incorporated into dressings allows for dilution and slow release therefore decreased toxicity

• Iodine, silver, and honey currently meet US and EU safety requirements

Page 93: Indi Adressing Final

The Ideal Antiseptic

• Effective against likely contaminants and pathogens

• Fast acting with prolonged activity

• Inexpensive, widely available

• Incapable of promoting bacterial resistance

• Minimal systemic absorption

• Noncarcinogenic, nontoxic

Page 94: Indi Adressing Final

The Antiseptic Dilemma

• Very little good research regarding their use

• An animal model for the chronic wound does not exist

Page 95: Indi Adressing Final
Page 96: Indi Adressing Final

Iodine

• Natural element discovered in 1811

• Molecular iodine very toxic to living tissue

• Formulations of iodine and a carrier molecule facilitates decreased iodine availability

• Povidine iodine = molecular iodine plus polyvinylpyrrolidine

Page 97: Indi Adressing Final

Povidine Iodine

• Solution, cream, ointment, scrub

• Scrub has detergent and should only be used on intact skin

• Effective in reducing the bacterial load

• 1% solution appears optimal (toxicity is

concentration dependant)

Page 98: Indi Adressing Final
Page 99: Indi Adressing Final

Iodine - cadexomer

• Spherical hydrophilic (water loving) beads of cadexomer starch which contain iodine

• Highly absorbent

• Release iodine slowly into the wound

• Sheet, gel, spray

• Iodosorb,iodoflex

Page 100: Indi Adressing Final
Page 101: Indi Adressing Final

Iodosorb/iodoflex indications

• Chronic exuding wounds : leg ulcers, pressure ulcers, diabetic ulcers

• Especially when critical colonization suspected (MRSA, Pseudomonas)

• Dressing change dictated by color loss usually at 3 days

• Apply 3 mm thick, covered with a secondary dressing

• Removal facilitated by gentle irrigation

Page 102: Indi Adressing Final

Iodosrb/Iodoflex contraindictions

• Iodine sensitivity• Hashimoto’s thyroiditis• Non toxic nodular goiter• Avoid prolonged use in renal insufficiency

and history of thyroid disorder• Pregnancy• Hildren• Lithium use should not exceed 3 months

Page 103: Indi Adressing Final

Iodine - cadexomer

• Studies (9) support that these dressings create environment of less pain, less exudate, more rapid development of granulation tissue

• Positive effects on epidermal regeneration

• May be a potent agent against Staph aureus, MRSA (multiple strains differing iodine kill levels, in vitro vs in vivo)

Page 104: Indi Adressing Final

Hydrogen Peroxide

• Limited bactericidal effectiveness in vivo

• Toxic to fibroblasts

• Impairs wound microcirculation

• Mechanical effect of “fizz” questionable

• Avoid in newly formed epithelium

Page 105: Indi Adressing Final

Hydrogen Peroxide

• 3 % solution is most commonly used wound antiseptic

• Catalases in wound tissue decrease bactericidal effect

• In vitro broad spectrum antibacterial efficacy (gram +)

• Few studies look at it’s efficay

Page 106: Indi Adressing Final

Honey

• Evidence of antibacterial activity against upto 70 different bacterial species

• Manuka Honey active against MRSA, and VRE ( vancomycin resistant enterococci)

• Mechanism?

• Very little good literature

Page 107: Indi Adressing Final

Chlorhexidine

• 1946

• Widely used in hand washing, surgical scrubs

• Rapid bactericidal activity

• Active against Stap aureus, Pseudomonas

• MRSA rseistance has been reported

Page 108: Indi Adressing Final

Antiseptics

• Povidine- iodine, chlorhexidine, hydrogen peroxide, and 0.25% acetic acid have been shown to interfere with fibroblast formation and epithelial growth

• The selected use of topical antiseptics should be reserved for wounds that do not have the ability to heal, or for the time – limited use in wounds where bacterial burden is more important than cellular toxicity.

Page 109: Indi Adressing Final

Wounds without the ability to Heal

Page 110: Indi Adressing Final

Wounds where bacterial burden outweighs cellular toxicity

Page 111: Indi Adressing Final

Four stages of life

Page 112: Indi Adressing Final

Silver

• Ancient Greece and Rome silver coins were dropped in water to act as a disinfectant

• 1884 1% silver nitrate eye drops used to eliminate blindness caused by postpartum infection

• 1964,1968 silver sulfadiazine (SSD) usedin burns

Page 113: Indi Adressing Final

Silver

• Acts as a heavy metal impairing bacterial electron transport

• Occurs only when silver ion Ag+ available to enter the cell at correct concentration

• In any formulation the way silver is incorporated and how it interacts with micro organisms over time is critical

Page 114: Indi Adressing Final

Silver

• Few if any clinical evidance study results are available to support specific silver products

• Genetic basis of bacterial resistance to silver has been identified

• 80 known stains of MRSA, bacteriacidal activity against all strains was achieved only after 60 ppm silver concentration

• SSD delivers in excess of 3,000 ppm, Aqucel Ag 1 to 2 ppm, Actioat 50 to 100 ppm ( deionized purified sterile water!)

Page 115: Indi Adressing Final
Page 116: Indi Adressing Final
Page 117: Indi Adressing Final
Page 118: Indi Adressing Final

Honey

• C.50AD Dioscorides described honey as “good for all rotten and hollow ulcers”

• Inhibitory to 60 bacterial species, also antifungal• Hyperosmolar• Parodoxically dilution increases antibacterial

proprties by increasing hydrogen peroxide production

• Manuka Honey from New Zealand, unique phytochemical comonent

Page 119: Indi Adressing Final

Critical colonization

• Colonized wounds are present for longer, are larger and have significantly delayed healing time when compared with ulcers where n bacterial growth is found

• “early and appropriate intervention using silver- or iodine- containing dressings in particular can avoid progression to critical colonization and infection, thus potentially improving healing rates and reducing the risk of cross contamination”

Page 120: Indi Adressing Final
Page 121: Indi Adressing Final
Page 122: Indi Adressing Final
Page 123: Indi Adressing Final
Page 124: Indi Adressing Final
Page 125: Indi Adressing Final

Negative pressure wound therapy – proposed mechanisms

• Remove exudate• Provides a moist environment• Removes slough• Decrease wound bacterial burden (?)• Reduces local edema• Increased perfusion pressure• Increases production of growth factors,

promotes leukocytes, fibroblasts

Page 126: Indi Adressing Final

Negative pressure wound therapy

• “Kremlin papers”, 5 articles, 1986 to 1998

• Vacuum assisted debridement, -100 mmHg, Rx time 5 to 10 min; significant reduction in bioburden, and improved wound healing

• Vacuum assisted treatment of lactation mastitis, negative pressure treatment 2x daily; improved ab titers, increased t cells, reduced bacterial load and septic complications, significantly reduced scarring

Page 127: Indi Adressing Final

V.A.C.

• 1997 Monykwas and Argenta described their experience with subatmospheric pressure delivered to open wounds for a period of upto 48 hours

• Interfaced with polyurethane sponge which allows for even distribution of pressure

Page 128: Indi Adressing Final
Page 129: Indi Adressing Final
Page 130: Indi Adressing Final
Page 131: Indi Adressing Final

Negative pressure wound therapy

Page 132: Indi Adressing Final
Page 133: Indi Adressing Final

Living Skin Equivalents

Page 134: Indi Adressing Final

Why Cell Therapy for Chronic Wounds?

• Smartness – cells are able to adapt to theirmicro environment

• Knowledge base – cells may bypass our lackof knowledge about what is required in specific situations

• Commercially available – cells are readily available as primary cultures, off the shelf products

• Manipulation – cells can be genetically manipulated

Page 135: Indi Adressing Final

Human Dermal FibroblastsHuman Dermal FibroblastsConnective Tissue ProteinsConnective Tissue Proteins

Dermal MatrixDermal Matrix

Human Epidermal Human Epidermal KeratinocytesKeratinocytes

ApligrafApligraf

Apligraf ®— Manufacturing Process

Data on file, Organogenesis Inc., Canton, MA.Data on file, Organogenesis Inc., Canton, MA.

Page 136: Indi Adressing Final

Parentau NL, et al. Parentau NL, et al. J Cell BiochemJ Cell Biochem. 1991;45:245-251.. 1991;45:245-251.

Page 137: Indi Adressing Final

ApligrafApligraf ®®

Why Fibroblasts and Keratinocytes?Why Fibroblasts and Keratinocytes?

Page 138: Indi Adressing Final

InjuryInjury HoursHours DaysDays WeeksWeeks

CoagulationCoagulationProcessProcess

InflammatoryInflammatoryProcessProcess

Migratory/Migratory/ProliferativeProliferativeProcessProcess

RemodelingRemodelingProcessProcess

PlateletsPlatelets

PlateletsPlateletsMacrophagesMacrophagesNeutrophilsNeutrophils

FibroblastsFibroblasts

Cell Types InvolvedCell Types Involved

Kane DP, Krasner D. Inc. Kane DP, Krasner D. Inc. Chronic Wound CareChronic Wound Care. 2nd ed. Health Management Publications Inc; 1997:1-. 2nd ed. Health Management Publications Inc; 1997:1-4.4.

Components of Wound Healing

MacrophagesMacrophagesLymphocytesLymphocytesFibroblastsFibroblasts

Epithelial cellsEpithelial cellsEndothelial cellsEndothelial cells

Page 139: Indi Adressing Final
Page 140: Indi Adressing Final

FibroblastFibroblastMigration/Migration/ProliferationProliferation

ProteaseProteasereleaserelease

ECMECMproductionproduction

Growth factor/Growth factor/cytokine productioncytokine production

AngiogenesisAngiogenesis

ECM = extracellular matrix.ECM = extracellular matrix.

Role of Fibroblasts in Wound Healing

Page 141: Indi Adressing Final
Page 142: Indi Adressing Final

ECM = extracellular matrix.ECM = extracellular matrix.

Role of Keratinocytesin Wound Healing

KeratinocyteKeratinocyteMigration/Migration/ProliferationProliferation

MatrixMatrixsynthesissynthesisregulationregulation

ECMECMproductionproduction

Growth factor/Growth factor/cytokine productioncytokine production

AngiogenesisAngiogenesis

Page 143: Indi Adressing Final

Hypotheses: Actual mechanisms of action are not known.Hypotheses: Actual mechanisms of action are not known.

1. Griffiths M, et al. 1. Griffiths M, et al. Tissue EngTissue Eng. 2004 Jul-Aug;10(7-8):1180-95.. 2004 Jul-Aug;10(7-8):1180-95.

Potential Mechanisms ofAction of Apligraf

® • Delivery of young, active fibroblasts and

keratinocytes • Demonstrated to show persistence of cells

in the wound out to 6 weeks1

• Production of new matrix material (fibronectin, vitronectin, proteoglycans) and cytokines and growth factors

• Recruitment of other cell types, including stem cells, to the non-healing wound

Page 144: Indi Adressing Final

FDA Approved for the Treatment ofFDA Approved for the Treatment ofVenousVenous and Diabetic Neuropathic Ulcers and Diabetic Neuropathic Ulcers

Apligraf ®

Page 145: Indi Adressing Final

AA BB

DDCC

Progression of Healing in a Venous Ulcer AfterProgression of Healing in a Venous Ulcer AfterExtensive Debridement and Apligraf Treatment Extensive Debridement and Apligraf Treatment

Page 146: Indi Adressing Final

FDA Approved for the Treatment ofFDA Approved for the Treatment ofVenous andVenous and Diabetic Neuropathic UlcersDiabetic Neuropathic Ulcers

Apligraf ®

Page 147: Indi Adressing Final

Diabetic Ulcer Healed With ApligrafDiabetic Ulcer Healed With Apligraf ®®: Treatment Sequence: Treatment Sequence

Page 148: Indi Adressing Final

Apligraf ® FDA Indications

• Indicated for the treatment of noninfected partial- and full-thickness venous leg ulcers with standard therapeutic compression – Ulcers that have not adequately responded to at least

4 weeks of conventional therapy

• Indicated for the treatment of full-thickness neuropathic diabetic foot ulcers when used with standard diabetic foot ulcer care– Ulcers that have not adequately responded to at least

3 weeks of conventional therapy